Asia Pacific Neurology Devices Market Outlook to Interventional Neurology Neurological Diagnostic Equipment Neurostimulation Devices and Others

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

MEDRAD, Inc. SWOT Analysis, Strategy, Revenues and Profits

MEDRAD, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: General Medicine and Specialty Medicine | Countries: United States, Australia, Brazil, Mexico, Sweden, Italy, France, Germany, Denmark, China

Tianyin Pharmaceutical Co., Inc. (Symbol:TPI) SWOT Analysis, Strategy, Revenues and Profits

Tianyin Pharmaceutical Co., Inc. (Symbol:TPI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Tianyin Pharmaceutical Co., Inc. SWOT Analysis report provides you ...

Industries: General Medicine and Specialty Medicine | Countries: China

Eifelhoehen-Klinik AG (Symbol:EIF) SWOT Analysis, Strategy, Revenues and Profits

Eifelhoehen-Klinik AG (Symbol:EIF) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Eifelhoehen-Klinik AG SWOT Analysis report provides you a strategic ...

Industries: General Medicine and Specialty Medicine | Countries: Germany, China

China Pediatric Pharmaceuticals Incorporation

China Pediatric Pharmaceuticals Incorporation

  • $ 55
  • Company report
  • by Wright Investors' Service
  • September 2014
  • 55 pages

A textual analysis of the financial results for China Pediatric Pharmaceuticals Incorporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security ...

Industries: General Medicine and Specialty Medicine | Countries: China

China Airway Stenting Procedures Outlook to 2020

China Airway Stenting Procedures Outlook to 2020

  • $ 175
  • Industry report
  • by Global Data
  • July 2014
  • 32 pages

China Airway Stenting Procedures Outlook to 2020 Summary GlobalData's new report, "China Airway Stenting Procedures Outlook to 2020", provides key market data on the China Airway Stenting Procedures. The report provides procedure volumes within market segments - Malignant Airway Obstruction Stenting ...

Industries: General Medicine and Specialty Medicine | Countries: China

China Endoscopic Reprocessors Market Outlook to 2020

China Endoscopic Reprocessors Market Outlook to 2020

  • $ 2 500
  • Industry report
  • by Global Data
  • July 2014
  • 29 pages

China Endoscopic Reprocessors Market Outlook to 2020 Summary GlobalData's new report, "China Endoscopic Reprocessors Market Outlook to 2020", provides key market data on the China Endoscopic Reprocessors market. The report provides value, in millions of US dollars, volume (in units) and average prices ...

Industries: General Medicine and Specialty Medicine | Countries: China

Asia-Pacific Pyeloplasty Procedures Outlook to 2020

Asia-Pacific Pyeloplasty Procedures Outlook to 2020

  • $ 450
  • Industry report
  • by Global Data
  • July 2014
  • 25 pages

Asia-Pacific Pyeloplasty Procedures Outlook to 2020 Summary GlobalData's new report, "Asia-Pacific Pyeloplasty Procedures Outlook to 2020", provides key market data on the Asia-Pacific Pyeloplasty Procedures. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology ...

Industries: General Medicine and Specialty Medicine | Countries: South Korea, Australia, Japan, India, China, Asia, World, Oceania

Asia-Pacific Uterine Fibroid Embolization (UFE) Procedures Outlook to 2020

Asia-Pacific Uterine Fibroid Embolization (UFE) Procedures Outlook to 2020

  • $ 450
  • Industry report
  • by Global Data
  • July 2014
  • 38 pages

Asia-Pacific Uterine Fibroid Embolization (UFE) Procedures Outlook to 2020 Summary GlobalData's new report, "Asia-Pacific Uterine Fibroid Embolization (UFE) Procedures Outlook to 2020", provides key market data on the Asia-Pacific Uterine Fibroid Embolization (UFE) Procedures. The report provides procedure ...

Industries: General Medicine and Specialty Medicine | Countries: South Korea, Australia, Japan, India, China, Asia

BRIC Pyeloplasty Procedures Outlook to 2020

BRIC Pyeloplasty Procedures Outlook to 2020

  • $ 450
  • Industry report
  • by Global Data
  • July 2014
  • 23 pages

BRIC Pyeloplasty Procedures Outlook to 2020 Summary GlobalData's new report, "BRIC Pyeloplasty Procedures Outlook to 2020", provides key market data on the BRIC Pyeloplasty Procedures. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to ...

Industries: General Medicine and Specialty Medicine | Countries: Brazil, Russian Federation, India, China

BRIC Uterine Fibroid Embolization (UFE) Procedures Outlook to 2020

BRIC Uterine Fibroid Embolization (UFE) Procedures Outlook to 2020

  • $ 450
  • Industry report
  • by Global Data
  • July 2014
  • 35 pages

BRIC Uterine Fibroid Embolization (UFE) Procedures Outlook to 2020 Summary GlobalData's new report, "BRIC Uterine Fibroid Embolization (UFE) Procedures Outlook to 2020", provides key market data on the BRIC Uterine Fibroid Embolization (UFE) Procedures. The report provides procedure volumes within market ...

Industries: General Medicine and Specialty Medicine | Countries: Brazil, Russian Federation, India, China

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.